All Stories

  1. Diverse MicroRNAs‐mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia
  2. TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
  3. Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma
  4. Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
  5. Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
  6. Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
  7. Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
  8. Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis
  9. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming
  10. Clustered protocadherins methylation alterations in cancer
  11. Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue loss
  12. High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist
  13. miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
  14. Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease
  15. Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis
  16. Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor
  17. Unacylated ghrelin prevents mitochondrial dysfunction in a model of ischemia/reperfusion liver injury
  18. GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease
  19. Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin–Driven Hepatocellular Cancer
  20. Estimation of a significance threshold for epigenome-wide association studies
  21. The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation
  22. A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
  23. Inducing liver regeneration in transplantation setting
  24. Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss
  25. The Dual Roles of NRF2 in Cancer
  26. T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair
  27. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
  28. The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival
  29. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules
  30. Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
  31. Reply to: “YAP in tumorigenesis: Friend or foe?”
  32. Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis
  33. Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats
  34. YAP activation is an early event and a potential therapeutic target in liver cancer development
  35. Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration
  36. Tri-iodothyronine induces hepatocyte proliferation by protein kinase a-dependent β-catenin activation in rodents
  37. Met as a therapeutic target in HCC: Facts and hopes
  38. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)
  39. MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
  40. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression
  41. MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer
  42. Gadd45β is an inducible coactivator of transcription that facilitates rapid liver growth in mice
  43. Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3
  44. Reply
  45. Proteomic Characterization of Early Changes Induced by Triiodothyronine in Rat Liver
  46. Gender-Specific Interplay of Signaling through β-Catenin and CAR in the Regulation of Xenobiotic-Induced Hepatocyte Proliferation
  47. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice
  48. Hepatocyte Growth, Proliferation and Experimental Carcinogenesis
  49. TRβ is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells
  50. The TR -selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine
  51. Progenitor-derived hepatocellular carcinoma model in the rat
  52. Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype
  53. Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration
  54. Thyroid hormone (T3) and TR  agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats
  55. Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation
  56.  -lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model
  57. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene
  58. Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells
  59. The Thyroid Hormone Receptor-β Agonist GC-1 Induces Cell Proliferation in Rat Liver and Pancreas
  60. Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes
  61. Induction of pancreatic acinar cell proliferation by thyroid hormone
  62. Gadd45β is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia
  63. Aging does not reduce the hepatocyte proliferative response of mice to the primary mitogen TCPOBOP
  64. Induction of hepatocyte proliferation by retinoic acid
  65. The peroxisome proliferator BR931 kills FaO cells by p53-dependent apoptosis
  66. Aging does not reduce the hepatocyte proliferative response of mice to the primary mitogen TCPOBOP
  67. A common set of immediate-early response genes in liver regeneration and hyperplasia
  68. Different Effects of the Liver Mitogens Triiodo-Thyronine and Ciprofibrate on the Development of Rat Hepatocellular Carcinoma
  69. Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth
  70. Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli
  71. Peroxisome proliferator–activated receptor-α−/− mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor
  72. Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes
  73. Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3)
  74. Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes
  75. Early Increase in Cyclin-D1 Expression and Accelerated Entry of Mouse Hepatocytes into S Phase after Administration of the Mitogen 1,4-Bis[2-(3,5-Dichloropyridyloxy)] Benzene
  76. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-?B and AP-1 or with expression of tumor necrosis factor ?
  77. Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP
  78. Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis
  79. Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha
  80. 9-Cis retinoic acid is a direct hepatocyte mitogen in rats
  81. Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis
  82. Genetic mapping and expression analysis of the murine DNA ligase I gene
  83. Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo
  84. Genotoxic and non-genotoxic activities of 2,4- and 2,6-diaminotoluene, as evaluated in Fischer-344 rat liver
  85. Different Effects of Regenerative and Direct Mitogenic Stimuli on the Growth of Initiated Cells in the Resistant Hepatocyte Model
  86. Involvement of DNA polymerase β in proliferation of rat liver induced by lead nitrate or partial hepatectomy
  87. Expression of the gene for poly(ADP-ribose) polymerase and DNA polymerase beta in rat tissues and in proliferating cells
  88. Stimulation of DNA synthesis by rat plasma following in vivo treatment with three liver mitogens
  89. Regulation of poly(ADP-ribose) polymerase mRNA levels during compensatory and mitogen-induced growth of rat liver
  90. Studies on the kinetics of expression of cell cycle dependent proto-oncogenes during mitogen-induced liver cell proliferation
  91. Induction of rat liver glutathione transferase subunit 7 by lead nitrate
  92. Liver cell proliferation induced by the mitogen ethylene dibromide, unlike compensatory cell proliferation, does not achieve initiation of rat liver carcinogenesis by diethylnitrosamine
  93. Cell proliferation in rat kidney induced by 1,2-dibromoethane
  94. Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis
  95. Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia
  96. Lead nitrate induces certain biochemical properties characteristic of hepatocyte nodules
  97. Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules
  98. Stimulation of DNA synthesis after a single administration of cadmium nitrate
  99. Stimulation of rat liver growth by a single administration of lead nitrate
  100. Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat☆
  101. Requirement of cell proliferation for the induction of presumptive preneoplastic lesions in rat liver by a single dose of 1,2-dimethylhydrazine
  102. Susceptibility of dimethylnitrosamine induced O6-methylguanine containing regions in in vivo replicated, hybrid rat liver DNA towards S1 nuclease☆
  103. In vivo replication of carcinogen-modified rat liver DNA: Increased susceptibility of 06-methylguanine compared to N-7-methylguanine in replicated DNA to S1-nuclease
  104. Differential effects of choline administration on liver microsomes of female and male rats
  105. Effect of choline administration on the toxicity of N-nitrosodimethylamine in female rats